Skip to main content

China dismisses researchers over gene therapy study linked to child’s death

China dismisses researchers over gene therapy study linked to child’s death
— Photo: Anadolu Agency

Two researchers were dismissed and five senior hospital officials disciplined after an investigation found safety, ethics and risk-disclosure failures. Investigators said they found no evidence of fabricated data in the study.

ru

Preparing…

The summary was written by AI from this story's own text.

That did not work. Please try again a little later.

China has dismissed two medical researchers and disciplined five senior hospital officials after an investigation into a controversial gene therapy study involving the death of a child, according to findings released Friday.

Anadolu Agency reported that the investigation examined research conducted at Xinhua Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. The inquiry was reported by Chinese news outlet The Paper.

The researchers, identified by the surnames Qiu and Yang, were dismissed, barred from taking part in research projects or receiving awards for five years, and placed on a national research integrity blacklist. Yang was an associate researcher at the hospital and the study’s first co-author.

Five senior hospital officials also received disciplinary penalties, including demotions and formal warnings.

Investigators found failures in safety assessments, ethical reviews and disclosure of risks associated with the experimental treatment.

The inquiry found that the child’s family had provided 5.337 million yuan ($750,000) in research funding, while researchers received additional money and gifts.

However, investigators said they found no evidence that data had been fabricated in the research paper published in the scientific journal “Nature”.

The findings were released by a Shanghai municipal investigation team following an inquiry launched in July.

OMM Bot · Shall I show you today’s 5 most read stories?

Author

Editorial board

All their articles ›
Loading next story…